...
首页> 外文期刊>Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases >Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules
【24h】

Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules

机译:预测结核分枝杆菌mymA操纵子蛋白与MHC I类和II类分子结合的混杂T细胞抗原表位

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Limited efficacy of Bacillus Calmette-Guerin vaccine has raised the need to explore other immunogenic candidates to develop an effective vaccine against Mycobacterium tuberculosis (Mtb). Both CD4+ and CD8+ T cells play a critical role in host immunity to Mtb. Infection of macrophages with Mtb results in upregulation of mymA operon genes thereby suggesting their importance as immune targets. In the present study, after exclusion of self-peptides mymA operon proteins of Mtb were analyzed in silico for the presence of Human Leukocyte Antigen (HLA) Class I and Class II binding peptides using Bioinformatics and molecular analysis section, NetMHC 3.4, ProPred and Immune epitope database software. Out of 56 promiscuous epitopes obtained, 41 epitopes were predicted to be antigenic for MHC Class I. In MHC Class II, out of 336 promiscuous epitopes obtained, 142 epitopes were predicted to be antigenic. The comparative bioinformatics analysis of mymA operon proteins found Rv3083 to be the best vaccine candidate. Molecular docking was performed with the most antigenic peptides of Rv3083 (LASGAASVV with alleles HLA-B51:01, HAATSGTLI with HLA-A02, IVTATGLNI and EKIHYGLKVNTA with HLA-DRB1_01:01) to study the structural basis for recognition of peptides by various HLA molecules. The software binding prediction was validated by the obtained molecular docking score of peptide-HLA complex. These peptides can be further investigated for their immunological relevance in patients of tuberculosis using major histocompatibility complex tetramer approach. (C) 2016 Elsevier B.V. All rights reserved.
机译:卡介苗芽孢杆菌(Bacillus Calmette-Guerin)疫苗的功效有限,因此需要探索其他免疫原性候选物来开发抗结核分枝杆菌(Mtb)的有效疫苗。 CD4 +和CD8 + T细胞在宿主对Mtb的免疫中都起着至关重要的作用。用Mtb感染巨噬细胞会导致mymA操纵子基因的上调,从而表明它们作为免疫靶标的重要性。在本研究中,使用生物信息学和分子分析部分,NetMHC 3.4,ProPred和免疫分析,在排除自身肽后,在计算机上分析了Mtb的mymA操纵子蛋白是否存在人类白细胞抗原(HLA)I类和II类结合肽。表位数据库软件。在获得的56个混杂表位中,预测有41个表位对I类MHC具有抗原性。在II类MHC中,在获得的336个混杂表位中,预测有142个表位具有抗原性。对mymA操纵子蛋白进行的比较性生物信息学分析发现Rv3083是最佳的候选疫苗。对Rv3083最具抗原性的肽段进行分子对接(LASGAASVV与等位基因HLA-B51:01,HAATSGTLI与HLA-A02,IVTATGLNI和EKIHYGLKVNTA与HLA-DRB1_01:01)研究了各种HLA分子识别肽的结构基础。通过获得的肽-HLA复合物的分子对接得分验证了软件结合预测。可以使用主要组织相容性复合体四聚体方法进一步研究这些肽在结核病患者中的免疫学相关性。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号